Case Reports
15 May 2025

Incidental identification of an aorto-right ventricular fistula formation years post TAVR

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
20
Views
9
Downloads

Authors

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure for treating aortic stenosis. However, it can lead to complications, such as ventricular septal defects (VSD). Although rare, these defects may result in hemodynamic instability and require intervention. An 82-year-old male with a history of Edwards SAPIEN TAVR and heart failure presented with dyspnea, fatigue, and complete heart block. An electrocardiogram showed a heart block, and a transesophageal echocardiogram revealed a mild paravalvular leak and an outlet VSD at the aortic annulus. Cardiac catheterization confirmed a Qp/Qs ratio of 1.68. After pacemaker implantation, the patient remained stable, and conservative management was pursued with outpatient follow-up. Aorto-right ventricular fistula is a rare late complication of TAVR. Clinicians should consider VSD in patients with complete heart block and a TAVR history, and regular echocardiographic surveillance may be warranted for symptomatic patients.

Altmetrics

Downloads

Download data is not yet available.

Citations

1. Siddiqullah S, Hsiung I, Potluri SP, Wang Z. Iatrogenic ventricular septal defect (VSD) treated with amplatzer pfo occluder device following valve in valve (VIV) tavr. J Am Coll Cardiol 2023;81:S2862. DOI: https://doi.org/10.1016/S0735-1097(23)03306-5
2. Ando T, Holmes AA, Taub CC, et al. Iatrogenic ventricular septal defect following transcatheter aortic valve replacement: a systematic review. Heart Lung Circ 2016;25:968-74. DOI: https://doi.org/10.1016/j.hlc.2016.03.012
3. Urbanczyk JP, Mixon TA, Konda S, Caldera AE. Iatrogenic ventricular septal defects following transcatheter aortic valve implantation. Proc (Bayl Univ Med Cent) 2022;36:106-8. DOI: https://doi.org/10.1080/08998280.2022.2119543
4. Zeniou V, Chen S, Gilon D, et al. Ventricular septal defect as a complication of TAVI: mechanism and incidence*. Struct Heart 2018;2:235-9. DOI: https://doi.org/10.1080/24748706.2018.1434580
5. Abril Molina A, Fernández Quero M, López Haldón JE, et al. An unusual complication after transcatheter aortic valve implantation: a case report. Eur Heart J Case Rep 2024;8:ytae045. DOI: https://doi.org/10.1093/ehjcr/ytae045
6. Ohlow MA, Schreiber M, Lauer B. Percutaneous closure of an iatrogenic ventricular septal defect following transcatheter aortic valve implantation. J Cardiol Cases 2017;16:165-7. DOI: https://doi.org/10.1016/j.jccase.2017.07.004
7. Sardar MR, Khan ZA, Abraham A, et al. Management strategies and possible risk factors for ventricular septal defects after transcatheter aortic valve replacement: Case series from a single center and review of literature. Cardiovasc Revasc Med 2017;18:462-70. DOI: https://doi.org/10.1016/j.carrev.2017.04.003
8. Pasic M, Unbehaun A, Buz S, et al. Annular rupture during transcatheter aortic valve replacement: classification, pathophysiology, diagnostics, treatment approaches, and prevention. JACC Cardiovasc Interv 2015;8:1-9. DOI: https://doi.org/10.1016/j.jcin.2014.07.020
9. Mark SD, Prasanna V, Ferrari VA, Herrmann HC. Percutaneous ventricular septal defect closure after sapien 3 transcatheter aortic valve replacement. JACC Cardiovasc Interv 2015;8:e109-10. DOI: https://doi.org/10.1016/j.jcin.2015.01.034
10. Massabuau P, Dumonteil N, Berthoumieu P, et al. Left-to-right interventricular shunt as a late complication of transapical aortic valve implantation. JACC Cardiovasc Interv 2011;4:710-2. DOI: https://doi.org/10.1016/j.jcin.2010.11.018
11. Rene AG, Jagasia D, Wickramasinghe SR, et al. New ventricular septal defects following balloon-expandable transcatheter aortic valve replacement. J Invasive Cardiol 2016;28:E59-65.
12. Chia R, Kalutota C, Cao K, et al. Management of aorto-right ventricular fistulas after TAVR. JACC Case Rep 2024;29:102655. DOI: https://doi.org/10.1016/j.jaccas.2024.102655
13. Kossar AP, Ravalli F, George I, et al. Aortic root replacement for a TAVR-induced aortic root-to-right ventricular fistula. Ann Thorac Surg 2020;110:e319-21. DOI: https://doi.org/10.1016/j.athoracsur.2020.01.067
14. Jakulla RS, Gunta SP, Huded CP. Heart failure after aortic valve replacement: incidence, risk factors, and implications. J Clin Med 2023;12:6048. DOI: https://doi.org/10.3390/jcm12186048
15. Mach M, Okutucu S, Kerbel T, et al. Vascular complications in TAVR: incidence, clinical impact, and management. J Clin Med 2021;10:5046. DOI: https://doi.org/10.3390/jcm10215046
16. Otto CM, Kumbhani DJ, Alexander KP, et al. 2017 ACC Expert Consensus Decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 2017;69:1313-46. DOI: https://doi.org/10.1016/j.jacc.2016.12.006
17. Coisne A, Lancellotti P, Habib G, et al. ACC/AHA and ESC/EACTS guidelines for the management of valvular heart diseases. J Am Coll Cardiol 2023;82:721-34. DOI: https://doi.org/10.1016/j.jacc.2023.05.061
18. Dakkak W, Alahmadi MH, Oliver TI. Ventricular septal defect. In: StatPearls [Internet]. Treasure Island, StatPearls Publishing; 2025.

How to Cite



1.
Le PH, Le TA, Vance J, Allen DH, Walid I. Incidental identification of an aorto-right ventricular fistula formation years post TAVR. Adv Health Res [Internet]. 2025 May 15 [cited 2025 May 17];2. Available from: https://www.ahr-journal.org/site/article/view/36